Scotiabank Weighs in on Savaria's FY2027 Earnings (TSE:SIS)

Key Points

• Scotiabank slightly lowered Savaria’s FY2027 EPS forecast to C$1.50 from C$1.51, still above the broader consensus estimate of C$1.20.
• Analyst sentiment remains positive: Savaria has a consensus “Buy” rating from ten analysts and an average price target of C$34.35, with several brokerages recently raising targets.
• Savaria shares opened at C$30.15, while insiders have sold 74,511 shares worth about C$2.24 million over the past 90 days; insiders retain a 17.45% ownership stake.

Savaria Co. (TSE:SIS - Free Report) - Equities research analysts at Scotiabank decreased their FY2027 earnings per share (EPS) estimates for Savaria in a note issued to investors on Thursday, October 22nd. Scotiabank analyst J. Goldman now anticipates that the company will post earnings per share of $1.50 for the year, down from their previous forecast of $1.51. The consensus estimate for Savaria's current full-year earnings is $1.20 per share.

A number of other brokerages also recently commented on SIS. ATB Cormark Capital Markets increased their price target on Savaria from C$35.00 to C$38.00 and gave the company an "outperform" rating in a research report on Friday, August 7th. TD upped their price objective on Savaria from C$35.00 to C$37.00 and gave the company a "buy" rating in a research note on Friday, August 7th. Ventum Financial set a C$34.50 target price on Savaria and gave the company a "buy" rating in a research report on Thursday, September 10th. Desjardins lifted their target price on Savaria from C$36.00 to C$39.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Finally, TD Securities upgraded Savaria to a "strong-buy" rating in a research note on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating and nine have given a Buy rating to the company. Based on data from MarketBeat.com, Savaria currently has a consensus rating of "Buy" and an average price target of C$34.35.

Savaria Price Performance

SIS opened at C$30.15 on Friday. The company has a debt-to-equity ratio of 29.43, a current ratio of 1.72 and a quick ratio of 0.91. The firm's fifty day moving average price is C$28.88 and its two-hundred day moving average price is C$29.22. Savaria has a 1 year low of C$20.72 and a 1 year high of C$31.95. The company has a market capitalization of C$2.17 billion, a price-to-earnings ratio of 24.92, a P/E/G ratio of 42.72 and a beta of 0.80.

Savaria (TSE:SIS - Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported C$0.35 earnings per share for the quarter. The company had revenue of C$245.78 million for the quarter. Savaria had a net margin of 9.27% and a return on equity of 13.41%.

Insider Activity

In related news, insider Jean-Philippe De Montigny sold 10,000 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of C$29.21, for a total transaction of C$292,100.00. Following the sale, the insider owned 82,560 shares of the company's stock, valued at approximately C$2,411,577.60. This represents a 10.80% decrease in their position. Also, Director Jean-Louis Chapdelaine sold 14,898 shares of the stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of C$30.24, for a total transaction of C$450,515.52. Following the completion of the sale, the director owned 100,000 shares in the company, valued at C$3,024,000. This represents a 12.97% decrease in their ownership of the stock. Insiders have sold 74,511 shares of company stock valued at $2,239,313 in the last 90 days. Insiders own 17.45% of the company's stock.

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.